1. Home
  2. ACHV vs ONL Comparison

ACHV vs ONL Comparison

Compare ACHV & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.98

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.86

Market Cap

141.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
ONL
Founded
N/A
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
141.5M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ACHV
ONL
Price
$4.98
$2.86
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$14.67
$3.00
AVG Volume (30 Days)
1.5M
316.6K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
2.83%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$147,647,000.00
Revenue This Year
N/A
$4.10
Revenue Next Year
N/A
$3.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$1.92
52 Week High
$6.16
$3.04

Technical Indicators

Market Signals
Indicator
ACHV
ONL
Relative Strength Index (RSI) 43.99 53.78
Support Level $4.09 $2.81
Resistance Level $4.98 $2.96
Average True Range (ATR) 0.42 0.09
MACD -0.05 -0.02
Stochastic Oscillator 8.59 44.44

Price Performance

Historical Comparison
ACHV
ONL

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

Share on Social Networks: